EQUITY RESEARCH MEMO

Amrex Electrotherapy

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)55/100

Amrex Electrotherapy is a privately held US medical device company based in Irvine, California, founded in 1990. The company specializes in manufacturing electrotherapy, ultrasound, and diathermy equipment for pain management and muscle rehabilitation. With a long history in the industry, Amrex focuses on delivering affordable, high-quality therapeutic solutions to healthcare providers. Despite its established presence, the company operates with limited public visibility and has not disclosed funding rounds or valuation. Its product portfolio addresses a consistent demand for non-invasive pain relief and rehabilitation devices, but growth prospects hinge on product innovation and market expansion. Given the competitive landscape dominated by larger players, Amrex's ability to differentiate through cost-effective offerings remains key. The company's private status and lack of recent financial or clinical milestones make conviction moderate.

Upcoming Catalysts (preview)

  • TBDLaunch of Next-Generation Electrotherapy Device60% success
  • TBDFDA 510(k) Clearance for New Diathermy Product70% success
  • TBDStrategic Distribution Partnership Expansion50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)